Pancreatic Cancer North America
  • PANCREATIC CANCER
    • OVERVIEW
      • THE PANCREAS
      • RISK FACTORS
      • SIGNS & SYMPTOMS
      • GENETIC TESTING
      • DIET AND NUTRITION
    • TREATMENT OPTIONS
  • HOW WE HELP
    • EARLY DETECTION AND SCREENING
    • IMPROVED TREATMENTS AND NOVEL APPROACHES
    • AWARENESS AND ADVOCACY
      • PANCREATIC CANCER AWARENESS MONTH
      • FIRE FIGHTING AND PANCREATIC CANCER
  • GET INVOLVED
    • HOST A FUNDRAISER
  • ABOUT US
    • OUR LEADERSHIP
    • NEWSROOM
    • CONTACT
  • DONATE
Select Page
Research Update – NeoPancONE Study Results Presented at ASCO 2025

Research Update – NeoPancONE Study Results Presented at ASCO 2025

by Tori Izzio-Meloche | Jun 13, 2025 | 2025 News

We were thrilled to see NeoPancONE, funded exclusively by our Canadian donors, showcased at the recent 2025 American Society of Clinical Oncology (ASCO) conference in Chicago. It was one of the most anticipated presentations spotlighting the progress being made...

Recent Posts

  • Research Update – NeoPancONE Study Results Presented at ASCO 2025
  • Fixing the language of cancer: why the words we use matter
  • Q & A with Dr. Eugene Koay
  • BBC News sounds the alarm on rising early onset pancreatic cancer rates
  • Announcement: Pancreatic Cancer North America and Pancreatic Cancer Canada announce funding for innovative early detection research project at MD Anderson 

Recent Comments

    • PANCREATIC CANCER
    • HOW WE HELP
    • GET INVOLVED
    • ABOUT US
    • FINANCIAL ACCOUNTABILITY
    • CONTACT US
    • Facebook
    • Twitter
    • Instagram